Search



You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 9 Next »


The first step in delivering comprehensive care is to undertake a clinical assessment. Clinical assessment data which can be recorded using SNOMED CT includes:

These data elements are described below, with example SNOMED CT subsets for each. For each subset member, we also indicate whether this concept is included in SNOMED International's Global Patient Set (GPS), which is available to be used internationally under the Creative Commons Attribution 4.0 International License.

2.3.1 Symptoms 

Symptoms represent physical or mental features which are regarded as an indication of a condition or disease, particularly those features that are apparent to the patientThis SNOMED CT subset of COVID-19 symptoms has been developed based on a range of literature, including relevant articles found in Pubmed 1, research performed by Kings College London 2 , and a review of COVID-19 data collection forms (e.g. 3). Please note that this subset includes the concept  84387000 | Asymptomatic (finding)| , which can be used to represent the absence of symptoms.

CV19-ASS-Symptoms
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
21522001Abdominal pain (finding)Abdominal pain20050131Yes
84387000Asymptomatic (finding)Asymptomatic20020131-
29857009Chest pain (finding)Chest pain20040731Yes
43724002Chill (finding)Chill20020131Yes
49727002Cough (finding)Cough20020131Yes
62315008Diarrhea (finding)Diarrhea20020131Yes
267036007Dyspnea (finding)Dyspnea20020131

Yes

271807003Eruption of skin (disorder)Eruption of skin20020731

Yes

84229001Fatigue (finding)Fatigue20020131Yes
103001002Feeling feverish (finding)Feeling feverish20020131-
386661006Fever (finding)Fever20030131Yes
25064002Headache (finding)Headache20100131Yes
66857006Hemoptysis (finding)Hemoptysis20020131Yes
79890006 |Loss of appetite (finding)Loss of appetite20020131Yes
44169009Loss of sense of smell (finding)Loss of sense of smell20200131Yes
36955009Loss of taste (finding)Loss of taste20020131-
367391008Malaise (finding)Malaise20020131Yes
68962001Muscle pain (finding)Muscle pain20020131Yes
64531003Nasal discharge (finding)Nasal discharge20020131Yes
422587007Nausea (finding)Nausea20070131Yes
162397003Pain in throat (finding)Pain in throat20020131Yes
422400008Vomiting (disorder)Vomiting20180731Yes

2.3.2 Severity 

Severity represents the quality of the condition - for example,  24484000 | Severe (severity modifier) (qualifier value)| . Severity may be recorded for each symptom, or as a general statement of their disease state 4

CV19-ASS-Severity
Concept idFully Specified Nameen-US Preferred TermEffective Time In GPS
255604002Mild (qualifier value)Mild20020131Yes
6736007Moderate (severity modifier) (qualifier value)Moderate20020131Yes
24484000Severe (severity modifier) (qualifier value)Severe20020131Yes
442452003Life threatening severity (qualifier value)Life threatening severity20090731Yes

2.3.3 Clinical Measurements 

Clinical measurements involve the performance of physiological tests to diagnose and refine therapeutic management of an already established disease. The following clinical measurements can be used in the assessment of a COVID-19 patient.

CV19-ASS-ClinicalMeasurements
Concept idFully Specified Nameen-US Preferred TermEffective TimeIn GPS
386725007Body temperature (observable entity)Body temperature20170131-
75367002Blood pressure (observable entity)Blood pressure20170131Yes
364075005Heart rate (observable entity)Heart rate20170131-
431314004Peripheral oxygen saturation (observable entity)Peripheral oxygen saturation
20080731-
86290005Respiratory rate (observable entity)Respiratory rate20170131Yes

2.3.4 Clinical Findings 

Clinical findings are the result of measuring, questioning, evaluating, or otherwise observing a patient or a specimen from a patient in healthcare. The following clinical findings are positive or negative indications that signs are present in a COVID-19 patient.

CV19-ASS-ClinicalFindings
Concept idFully Specified Nameen-US Preferred TermEffective TimeIn GPS
288848001Able to breathe (finding)Able to breathe20080731-
371632003Coma (disorder)Coma20020731Yes
193894004Conjunctival hyperemia (finding)Conjunctival hyperemia20100131-
267036007Dyspnea (finding)Dyspnea20020131Yes
126664009Exudative pharyngitis (disorder)Exudative pharyngitis20020131-
442646005Imaging of lung abnormal (finding)Imaging of lung abnormal20090731Yes
274710003Lung field abnormal (finding)Lung field abnormal20020131Yes
91175000Seizure (finding)Seizure20020131Yes
271823003Tachypnea (finding)Tachypnea20020131Yes
288849009Unable to breathe (finding)Unable to breathe20080731-

Please refer to 2.3.1 Extension Concepts - Clinical Assessment for a list of known extension concepts.

2.3.5 Diagnosis and Certainty 

A diagnosis is the identification of the nature of the illness, based on an examination of the symptoms, observations, measurements, test results and other investigation results. The following subset includes a range of diagnoses directly related to COVID-19.

CV19-ASS-Diagnosis
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
840539006Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)COVID-1920200131Yes
840544004Suspected disease caused by severe acute respiratory coronavirus 2 (situation)Suspected COVID-1920200131Yes
189486241000119100Asymptomatic severe acute respiratory syndrome coronavirus 2 infection (finding)Asymptomatic SARS-CoV-220200731-
688232241000119100Disease caused by severe acute respiratory syndrome coronavirus 2 absent (situation)Disease caused by severe acute respiratory syndrome coronavirus 2 absent20200731-

Please refer to 2.3.1 Extension Concepts - Clinical Assessment for a list of known COVID-19 diagnosis extension concepts.

To represent the certainty of a positive COVID-19 diagnosis, the following subset may be used in conjunction with a diagnosis of  840539006 | COVID-19| .

CV19-ASS-DiagnosisPresentCertainty
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
410605003Confirmed present (qualifier value)Confirmed present20040731-
410592001Probably present (qualifier value)Probably present20040731-
415684004Suspected (qualifier value)Suspected20050131Yes

To represent the certainty of the absence of COVID-19, the following subset may be used in conjunction with a diagnosis of  688232241000119100 | Disease caused by severe acute respiratory syndrome coronavirus 2 absent (situation)|  (to be published 20200731).

CV19-ASS-DiagnosisAbsentCertainty
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
410594000Definitely NOT present (qualifier value)Definitely NOT present20040731-
410593006Probably NOT present (qualifier value)Probably NOT present20040731-

2.3.6 Clinical History 

The clinical history concepts are used to record information gained by a physician by asking specific questions, either of the patient or of other people who know the person and can give suitable information, with the aim of obtaining information useful in formulating a diagnosis and providing medical care to the patient.

CV19-ASS-ClinicalHistory
Concept idFully Specified Nameen-US Preferred TermEffective TimeIn GPS

292508471000119105

History of disease caused by severe acute respiratory syndrome coronavirus 2 (situation)

History of SARS-CoV-2

20200731-

2.3.7 Secondary Conditions and Complications 

A secondary condition is any additional health condition that occurs as a result of the natural progression or expected outcome of the primary condition. A complication is "a disorder caused by another disorder, procedure or event, which is not a natural progression or expected outcome of its cause 5.

The following subset includes SNOMED CT clinical findings that may be recorded as either secondary conditions or complications 6. Clinical judgement is required to determine whether these conditions are expected outcomes or unexpected complications of COVID-19. 

CV19-ASS-SecondaryConditionsAndComplications
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
373895009Acute respiratory distress (finding)Acute respiratory distress20020731-
67782005Acute respiratory distress syndrome (disorder)Acute respiratory distress syndrome20020131Yes
62914000Cerebrovascular disease (disorder)Cerebrovascular disease20020131Yes
710027002Cytokine-associated toxicity (disorder)Cytokine-associated toxicity20150731-
3006004Disturbance of consciousness (finding)Disturbance of consciousness20020131-
56265001Heart disease (disorder)Heart disease20020131Yes
419099009Dead (finding)Dead20060131Yes
25374005Gastroenteritis (disorder)Gastroenteritis20020131Yes
90708001Kidney disease (disorder)Kidney disease20020731Yes
302846007Rhabdomyoma (disorder)Rhabdomyoma20040731-
308906005Secondary bacterial pneumonia (disorder)Secondary bacterial pneumonia20160131-
429340002Traumatic injury of skeletal muscle (disorder)Traumatic injury of skeletal muscle20080131-
75570004Viral pneumonia (disorder)Viral pneumonia20130731Yes

138389411000119105

Acute bronchitis caused by severe acute respiratory syndrome coronavirus 2 (disorder)

Acute bronchitis caused by SARS-CoV-220200731-
870590002Acute hypoxemic respiratory failure due to disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)Acute hypoxemic respiratory failure due to disease caused by severe acute respiratory syndrome coronavirus 220200731-
870589006Acute kidney injury due to disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)Acute kidney injury due to disease caused by severe acute respiratory syndrome coronavirus 220200731-
674814021000119106

Acute respiratory distress syndrome caused by severe acute respiratory syndrome coronavirus 2 (disorder)

Acute respiratory distress syndrome due to disease caused by severe acute respiratory syndrome coronavirus 2

20200731-
119731000146105Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731-
119741000146102Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731-
1240561000000108Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731-
1240541000000107Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2
20200731-

880529761000119102

Lower respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (disorder)

Lower respiratory infection caused by SARS-CoV-2

20200731-
866151004Lymphocytopenia associated with severe acute respiratory syndrome coronavirus 2 (disorder)Lymphocytopenia associated with severe acute respiratory syndrome coronavirus 220200731-
1240531000000103Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2
20200731-
1240521000000100Otitis media due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Otitis media due to disease caused by Severe acute respiratory syndrome virus 2
20200731-

441590008

Pneumonia caused by Severe acute respiratory syndrome coronavirus (disorder)

Pneumonia due to Severe acute respiratory syndrome coronavirus

20200731-
870591003Rhabdomyolysis due to disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)Rhabdomyolysis due to disease caused by severe acute respiratory syndrome coronavirus 220200731-
870588003Sepsis due to disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)Sepsis due to disease caused by severe acute respiratory syndrome coronavirus 220200731-

866152006

Thrombocytopenia associated with severe acute respiratory syndrome coronavirus 2 (disorder)Thrombocytopenia associated with severe acute respiratory syndrome coronavirus 220200731-

Please refer to 2.3.1 Extension Concepts - Clinical Assessment for a list of known extension concepts.

2.3.8 Risk Factors 

Risk factors are the known patient conditions which may increase the risk of the patient being especially vulnerable to the COVID-19 virus. The following clinical findings have been identified as potential risk factors of COVID-19 3 7 8.

CV19-ASS-RiskFactors
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
111273006Acute respiratory disease (disorder)Acute respiratory disease20020131-
195967001Asthma (disorder)Bronchial hypersensitivity20040731Yes

78648007

At risk for infection (finding)

At risk for infection

20020131Yes
27624003Chronic disease (disorder)Chronic disease20020131-
413834006Chronic disease of immune function (disorder)Chronic disease of immune function20050131-
17097001Chronic disease of respiratory system (disorder)Chronic respiratory system disease20020131-
128238001Chronic heart disease (disorder)Chronic disorder of heart20020131-
709044004Chronic kidney disease (disorder)Chronic kidney disease20150731Yes
328383001Chronic liver disease (disorder)Chronic liver disease20090731Yes

128283000

Chronic nervous system disorder (disorder)

Chronic nervous system disorder

20020131-
13645005Chronic obstructive lung disease (disorder)Chronic obstructive lung disease20020131Yes
13213009Congenital heart disease (disorder)CHD - Congenital heart disease20030731Yes
190905008Cystic fibrosis (disorder)Cystic fibrosis20020131Yes
73211009Diabetes mellitus (disorder)Diabetes mellitus20020131Yes
414029004Disorder of immune function (disorder)Disorder of immune function20190131-
8517006Ex-smoker (finding)Ex-smoker20020131Yes
38341003Hypertensive disorder, systemic arterial (disorder)Hypertensive disorder20020131Yes
700250006Idiopathic pulmonary fibrosis (disorder)Idiopathic pulmonary fibrosis20190731Yes

234532001

Immunodeficiency disorder (disorder)

Immunodeficiency disorder

20020131Yes
370388006Patient immunocompromised (finding)Patient immunocompromised20020731Yes
370391006Patient immunosuppressed (finding)Patient immunosuppressed20020731-
363346000Malignant neoplastic disease (disorder)Malignant neoplastic disease20020131Yes
414825006Neoplasm of hematopoietic cell type (disorder)Neoplasm of hematopoietic cell type20050131-
126713003Neoplasm of lung (disorder)Neoplasm of lung20020131Yes
414915002Obese (finding)Obese20050131Yes
77386006Pregnant (finding)Pregnant20020131Yes
6383007Premature labor (finding)Premature labor20020131Yes
31323000Severe combined immunodeficiency disease (disorder)Severe combined immunodeficiency disease20020131-
127040003Sickle cell-hemoglobin SS disease (disorder)Sickle cell-hemoglobin SS disease20020131Yes
77176002Smoker (finding)Smoker20020131Yes

The following procedures have been identified as potential risk factors of COVID-19 8

CV19-ASS-ProcedureRiskFactors
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
367336001Chemotherapy (procedure)Chemotherapy20020131Yes
788751009Corticosteroid and corticosteroid derivative therapy (procedure)Corticosteroid and corticosteroid derivative therapy20200131-
234336002Hemopoietic stem cell transplant (procedure)Hemopoietic stem cell transplant20050131Yes
86553008Immunosuppressive therapy (procedure)Immunosuppressive therapy20020131Yes
76334006Immunotherapy (procedure) Immunological therapy20020131-
108290001Radiation oncology AND/OR radiotherapy (procedure)Radiation oncology AND/OR radiotherapy20020131Yes
312235007Radiolabeled antibody therapy (procedure)Radiolabeled antibody therapy20020131-
313039003Solid organ transplant (procedure)Solid organ transplant20060731-

2.3.9 Comorbidities 

Comorbidities are additional medical conditions of concern. The following SNOMED CT subset can be used to record comorbidities.

CV19-ASS-Comorbidities

Intensional Definition:

Intensional Definition:

64572001 |Disease (disorder)|

2.3.10 Exposure 

An exposure event is when an individual comes into close contact with an infected person's contaminated droplets, carried in the air or on contaminated hands, surfaces or other objects. The subset below includes SNOMED CT events for recording exposure to COVID-19.

CV19-ASS-ExposureEvent
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
840546002Exposure to severe acute respiratory syndrome coronavirus 2 (event)Exposure to SARS-CoV-220200131Yes

An exposure finding is the result of an observation or evaluation that relates to the patient's exposure to an infection. The subset below includes SNOMED CT findings relating to COVID-19 exposure.

CV19-ASS-ExposureFinding
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
870577009At increased risk of exposure to severe acute respiratory syndrome coronavirus 2 (finding)At increased risk of exposure to severe acute respiratory syndrome coronavirus 220200731-

Please refer to 2.3.1 Extension Concepts - Clinical Assessment for a list of known extension concepts.

2.3.11 Covid-19 and Viral Co-Infections 

The following organism should be used when recording the organism causing COVID-19 infections.

CV19-ASS-Organism
Concept idFully Specified Nameen-US Preferred TermEffective Time
In GPS
840533007Severe acute respiratory syndrome coronavirus 2 (organism)SARS-CoV-220200131Yes

The following organisms can be used to record the cause of related viral co-infections.

CV19-ASS-ViralCoInfections



Footnotes


Feedback
  • No labels